189 related articles for article (PubMed ID: 24480305)
1. Impact of changes in mortality on FRAX-derived fracture probabilities.
Kreidieh OI; El-Hajj Fuleihan G
Bone; 2014 May; 62():43-50. PubMed ID: 24480305
[TBL] [Abstract][Full Text] [Related]
2. Development and application of FRAX in the management of osteoporosis in Ireland.
McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
4. Fracture burden in relation to low bone mineral density and FRAX(®) probability.
Leslie WD; Morin S
J Clin Densitom; 2011; 14(3):279-85. PubMed ID: 21723761
[TBL] [Abstract][Full Text] [Related]
5. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
6. FRAX-based Estimates of 10-year Probability of Hip and Major Osteoporotic Fracture Among Adults Aged 40 and Over: United States, 2013 and 2014.
Looker AC; Sarafrazi Isfahani N; Fan B; Shepherd JA
Natl Health Stat Report; 2017 Mar; (103):1-16. PubMed ID: 28459415
[TBL] [Abstract][Full Text] [Related]
7. The effects of a FRAX revision for the USA.
Kanis JA; Johansson H; Oden A; Dawson-Hughes B; Melton LJ; McCloskey EV
Osteoporos Int; 2010 Jan; 21(1):35-40. PubMed ID: 19705047
[TBL] [Abstract][Full Text] [Related]
8. Effects of FRAX(®) model calibration on intervention rates: a simulation study.
Leslie WD; Lix LM;
J Clin Densitom; 2011; 14(3):272-8. PubMed ID: 21723769
[TBL] [Abstract][Full Text] [Related]
9. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
González-Macías J; Marin F; Vila J; Díez-Pérez A
Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).
Sund R; Honkanen R; Johansson H; Odén A; McCloskey E; Kanis J; Kröger H
Calcif Tissue Int; 2014 Jul; 95(1):39-45. PubMed ID: 24792689
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hip fracture in Romania and the development of a Romanian FRAX model.
Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
Calcif Tissue Int; 2013 May; 92(5):429-36. PubMed ID: 23334302
[TBL] [Abstract][Full Text] [Related]
12. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.
Pluskiewicz W; Adamczyk P; Franek E; Leszczynski P; Sewerynek E; Wichrowska H; Napiorkowska L; Kostyk T; Stuss M; Stepien-Klos W; Golba KS; Drozdzowska B
Bone; 2010 Jun; 46(6):1661-7. PubMed ID: 20156606
[TBL] [Abstract][Full Text] [Related]
13. Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.
Jaller-Raad JJ; Jaller-Char JJ; Lechuga-Ortiz JA; Navarro-Lechuga E; Johansson H; Kanis JA
Calcif Tissue Int; 2013 Jul; 93(1):15-22. PubMed ID: 23471427
[TBL] [Abstract][Full Text] [Related]
14. FRAX calculator and Garvan nomogram in male osteoporotic population.
Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Leszczynski P; Wichrowska H; Napiórkowska L; Stuss M; Ptaszek A; Kostyk T; Golba KS; Garbacz W; Drozdzowska B
Aging Male; 2014 Sep; 17(3):174-82. PubMed ID: 24456527
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
[TBL] [Abstract][Full Text] [Related]
16. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
[TBL] [Abstract][Full Text] [Related]
17. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
18. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.
Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA
Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948
[TBL] [Abstract][Full Text] [Related]
20. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
